Roswell Park is dedicated to accelerating access to the most promising immunotherapy treatments through clinical trials. Few institutions in the nation have the facilities for pre-treatment, manufacturing and post-treatment of immunotherapies and gene therapy clinical trials. With a recent investment from New York State and with the support of donors through the Igniting Cancer Breakthroughs campaign, Roswell Park has all of this, making it uniquely positioned to lead cutting-edge trials.
With your support, Roswell Park’s new cell production facilities will be ready to bring therapies to patients faster. Roswell Park experts will also be able to use the expanded facilities to bring existing treatments to more patients, participate in more clinical trials and research treatments that are still on the horizon.
“This is a time of tremendous hope and promise,” explains Dr. Brentjens. “Cellular therapy is in its infancy, but it’s already dramatically reshaping what we can achieve through cancer therapy. I’m incredibly excited about the work the team will do in the next few years — the time we are going to be able to give back to patients with even advanced cancers, the cures that are within our reach today.”
